Citigroup’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.82K | Sell |
|
|||||
|
2025
Q2 | $37.7K | Sell |
|
|||||
|
2025
Q1 | $102K | Sell |
|
|||||
|
2024
Q4 | $148K | Buy |
|
|||||
|
2024
Q3 | $84.1K | Buy |
|
|||||
|
2024
Q2 | $42.5K | Buy |
|
|||||
|
2024
Q1 | $14.2K | Buy |
|
|||||
|
2023
Q4 | $13.3K | Buy |
|
|||||
|
2023
Q3 | $1.94K | Sell |
|
|||||
|
2023
Q2 | $41.6K | Sell |
|
|||||
|
2023
Q1 | $265K | Sell |
|
|||||
|
2022
Q4 | $343K | Buy |
|
|||||
|
2022
Q3 | $23K | Buy |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $10K | Sell |
|
|||||
|
2021
Q4 | $90K | Sell |
|
|||||
|
2021
Q3 | $468K | Buy |
|
|||||
|
2021
Q2 | $50K | Sell |
|
|||||
|
2021
Q1 | $626K | Buy |
|
|||||
|
2020
Q4 | $52K | Buy |
|
|||||
|
2020
Q3 | $10K | Sell |
|
|||||
|
2020
Q2 | $28K | Sell |
|
|||||
|
2020
Q1 | $391K | Buy |
|
|||||
|
2019
Q4 | $2K | Sell |
|
|||||
|
2019
Q3 | $5K | Sell |
|
|||||
|
2019
Q2 | $16K | Sell |
|
|||||
|
2019
Q1 | $25K | Buy |
|
|||||
|
2018
Q4 | $16K | Buy |
|
|||||
|
2018
Q3 | $82K | Buy |
|
|||||
|
2018
Q2 | $4K | Sell |
|
|||||
|
2018
Q1 | $24K | Buy |
|
|||||
|
2017
Q4 | $1K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $3K | Sell |
|
|||||
|
2017
Q1 | $3K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $6K | Buy |
|